NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $259,336 | +0.9% | 2,546 | 0.0% | 0.06% | -32.6% |
| Q2 2023 | $256,917 | +9.7% | 2,546 | 0.0% | 0.09% | +41.3% |
| Q1 2023 | $234,232 | +1.4% | 2,546 | 0.0% | 0.06% | -8.7% |
| Q4 2022 | $230,973 | +7.4% | 2,546 | 0.0% | 0.07% | +1.5% |
| Q2 2022 | $215,000 | -3.6% | 2,546 | 0.0% | 0.07% | +15.3% |
| Q1 2022 | $223,000 | 0.0% | 2,546 | 0.0% | 0.06% | 0.0% |
| Q4 2021 | $223,000 | +7.2% | 2,546 | 0.0% | 0.06% | +3.5% |
| Q3 2021 | $208,000 | -10.3% | 2,546 | 0.0% | 0.06% | -1.7% |
| Q2 2021 | $232,000 | +6.4% | 2,546 | 0.0% | 0.06% | -3.3% |
| Q1 2021 | $218,000 | -9.2% | 2,546 | 0.0% | 0.06% | -15.5% |
| Q4 2020 | $240,000 | +8.6% | 2,546 | 0.0% | 0.07% | -1.4% |
| Q3 2020 | $221,000 | -0.5% | 2,546 | 0.0% | 0.07% | -6.5% |
| Q2 2020 | $222,000 | +5.7% | 2,546 | 0.0% | 0.08% | -25.2% |
| Q1 2020 | $210,000 | 0.0% | 2,546 | +14.8% | 0.10% | +45.1% |
| Q4 2019 | $210,000 | -76.8% | 2,217 | -81.8% | 0.07% | -71.4% |
| Q1 2017 | $906,000 | – | 12,200 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |